Affiliation:
1. Department of Dermatology Beaumont Hospital Dublin Ireland
2. Department of Histopathology Beaumont Hospital Dublin Ireland
Abstract
AbstractImmunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metastatic melanoma.